Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 4/2011

01-12-2011 | Urology – Original Paper

Renal tumor with tumor thrombus in inferior vena cava and right atrium: the report of five cases with long-term follow-up

Authors: Djordje Radak, Predrag Milojevic, Srdjan Babic, Predrag Matic, Slobodan Tanaskovic, Vinka Vukotic, Tomislav Pejcic, Jovan Hadzi-Djokic

Published in: International Urology and Nephrology | Issue 4/2011

Login to get access

Abstract

Objective

To evaluate early and long-term results of radical surgical removal of renal cell cancer (RCC) with tumor thrombus (TT) in the inferior vena cava (IVC) and right atrium (RA).

Methods

The study included five patients with RCC with TT in IVC and right atrium, operated from January 2004 to September 2009 in the Institute for Cardiovascular disease “Dedinje”, Belgrade, Serbia. All patients underwent atrial and caval thrombectomy with the use of normothermic cardiopulmonary bypass (CPB) and the radical nephrectomy, by a joint cardiovascular and urological team. After the surgery, patients were evaluated every 3 months for the first year, every 6 months for the next 2 years, and yearly thereafter. The mean follow-up was 32.6 months (range: 7–67 months).

Results

There were no per-operative embolism and no in-hospital deaths. Two patients developed tumor recurrence during a mean time of 5 months and died within 1 year after the surgery. The three remaining patients are alive (mean follow-up: 48 months) and without the evidence of tumor recurrence or metastases. No patients received adjuvant therapy.

Conclusions

Patients with RCC and the extension of TT in IVC and right atrium need a multidisciplinary surgical strategy. Atrial and caval tumor thrombectomy can be performed safely and effectively, with a low complication rate, using normothermic CPB. Long-term results are promising; however, larger prospective multicentre studies are necessary.
Literature
1.
2.
Wotkowicz C, Wszolek MF, Libertino JA (2008) Resection of renal tumors invading the vena cava. Urol Clin North Am 35:657–671PubMedCrossRef
3.
Tan YS, Yip KH, Tan PH, Cheng WS (2010) A right renal angiomyolipoma with IVC thrombus and pulmonary embolism. Int Urol Nephrol 42(2):305–308 Epub 2009 Jul 16PubMedCrossRef
4.
Berg AA (1913) Malignant hypernephroma of the kidney, its clinical course and diagnosis, with a description of the author’s method of radical operative cure. Surg Gynecol Obstet 17:446–471
5.
Nesbitt JC, Soltero ER, Walsh GL, Schrump DS, Swanson DA, Pisters LL et al (1997) Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63(6):1592–1600PubMedCrossRef
6.
Glazer AA, Novick AC (1996) Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol 155(2):448–450PubMedCrossRef
7.
Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS (2004) Prognostic significance of venous thrombus in renal cell carcinoma Are renal vein and inferior vena cava involvement different? J Urol 171(2 Pt 1):588–591CrossRef
8.
Libertino JA, Zinman L, Watkins E (1987) Long term results of renal cell cancer with extension into inferior vena cava. J Urol 137(1):21–24PubMed
9.
Ciancio G, Livingstone AS, Soloway M (2007) Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol 51:988–995PubMedCrossRef
10.
Glazer AA, Novick AC (1996) Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol 155(2):448–450PubMedCrossRef
11.
Rigaud Jérôme, Hetet Jean-François, Braud Guillaume, Battisti Simon, Normand LoïcLe, Glemain Pascal, Karam Georges, Bouchot Olivier (2006) Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990 s. Eur Urol 50:302–310PubMedCrossRef
12.
Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CPN (2003) Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol: seminars and original investigations 21: 327–333
13.
Cerwinka WH, Ciancio G, Salerno TA, Soloway MS (2005) Renal cell cancer with invasive atrial tumor thrombus excised off-pump. Urology 66(6):1319PubMedCrossRef
14.
Shinghal R, Vricella LA, Mitchell RS, Presti J Jr (2003) Cavoatrial tumor thrombus excision without circulatory arrest. Urology 62(1):138–140PubMedCrossRef
15.
Chowdhury UK, Mishra AK, Seth A, Dogra PN, Honnakere JHV, Subramaniam GK, Malhotra A, Malhotra P, Makhija N, Venugopal P (2007) Novel techniques for tumor thrombectomy for renal cell carcinoma with intraatrial tumor thrombus. Ann Thorac Surg 83:1731–1736PubMedCrossRef
16.
Gallucci M, Borzomati D, Flammia G, Alcini A, Albino G, Caricato M et al (2004) Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality. Eur Urol 45(2):194–202PubMedCrossRef
17.
Parissis H, Akbar MT, Tolan M, Young V (2010) Surgical resection of a renal cell carcinoma involving the inferior vena cava: the role of the cardiothoracic surgeon. J Cardiothorac Surg 5:103PubMedCrossRef
18.
Modine T, Haulon S, Zini L, Fayad G, Destrieux-Garnier L, Azzaoui R, Fantoni JC, Gourlay T, Villers A, Koussa M (2007) Surgical treatment of renal cell carcinoma with right atrial thrombus: early experience, description of a simplified technique. Int J Surg 5(5):305–310PubMedCrossRef
19.
Martinez-Salamanca JI, Huang WC, Millan I, Bertini R et al. (2010) Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol published online ahead of print on October 13, 2010
20.
Wagner B, Patard J-J, Mejean A et al (2009) Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 55:452–460PubMedCrossRef
21.
Staehler G, Brkovic D (2000) The role of radical surgery for renal cell carcinoma with extension into the vena cava. J Urol 163:1671–1675PubMedCrossRef
22.
Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM (2007) Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 69:1054–1058PubMedCrossRef
Metadata
Title
Renal tumor with tumor thrombus in inferior vena cava and right atrium: the report of five cases with long-term follow-up
Authors
Djordje Radak
Predrag Milojevic
Srdjan Babic
Predrag Matic
Slobodan Tanaskovic
Vinka Vukotic
Tomislav Pejcic
Jovan Hadzi-Djokic
Publication date
01-12-2011
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2011
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-9937-6

Other articles of this Issue 4/2011

International Urology and Nephrology 4/2011 Go to the issue

Urology – Original Paper

Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia

Urology – Original Paper

Effects of pulsed electromagnetic fields on benign prostate hyperplasia

Nephrology – Original Paper

Can the combination of calcium and parathormone levels above k/doqi guidelines be used as a marker of adynamic bone disease in African Americans?

Urology – Original Paper

Cryosurgery as primary treatment for localized prostate cancer

Nephrology - Original Paper

Correlation between glycated hemoglobin and mean plasma glucose in hemodialysis patients

Urology – Original Paper

Etiology and current clinical characteristics of male urethral stricture disease: experience from a public teaching hospital in Senegal
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits